4.7 Article

Characterization of Off-Target Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiad086

Keywords

live attenuated yellow fever vaccine; T-cell receptor; T lymphocyte; vaccine; Off-target vaccine effects; yellow fever virus; PTPRE

Ask authors/readers for more resources

Live attenuated vaccines such as the yellow fever virus vaccine can modulate immune functions, but they may also have off-target effects on T-cell receptor signaling, which could impact clinical outcomes.
Live attenuated vaccines induce beneficial clinical outcomes, thought to be due to immune modulation. After yellow fever virus vaccination, we observed a reduction in T-cell receptor signaling. This may be a potential off target effect that influences clinical outcomes. Background Live attenuated vaccines alter immune functions and are associated with beneficial outcomes. We previously demonstrated that live attenuated yellow fever virus (YFV) vaccine (LA-YF-Vax) dampens T-cell receptor (TCR) signaling in vitro via an RNA-based mechanism. We examined study participants before and after LA-YF-Vax to assess TCR-mediated functions in vivo. Methods Serum samples and peripheral blood mononuclear cells (PBMCs) were obtained before and after LA-YF-Vax (with or without additional vaccines) or quadrivalent influenza vaccine. TCR-mediated activation was determined by interleukin 2 release or phosphorylation of the lymphocyte-specific Src kinase. TCR-regulating phosphatase (protein tyrosine phosphatase receptor type E [PTPRE]) expression was also measured. Results Compared with prevaccination findings, LA-YF-Vax recipient PBMCs demonstrated transient reduction in interleukin 2 release after TCR stimulation and PTPRE levels, unlike in control participants who received quadrivalent influenza vaccine. YFV was detected in 8 of 14 participants after LA-YF-Vax. After incubation of healthy donor PBMCs in serum-derived extracellular vesicles prepared from LA-YF-Vax recipients, TCR signaling and PTPRE levels were reduced after vaccination, even in participants without detectable YFV RNA. Conclusions LA-YF-Vax reduces TCR functions and PTPRE levels after vaccination. Extracellular vesicles from serum recapitulated this effect in healthy cells. This likely contributes to the reduced immunogenicity for heterologous vaccines after LA-YF-Vax administration. Identification of specific immune mechanisms related to vaccines should contribute to understanding of the off-target, beneficial effects of live vaccines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available